Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Seasonal dynamics of the wild rodent faecal virome.

Raghwani J. et al, (2023), Mol Ecol, 32, 4763 - 4776

The roles of nucleic acid editing in adaptation of zoonotic viruses to humans.

Ratcliff J. and Simmonds P., (2023), Curr Opin Virol, 60

Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.

Wellens J. et al, (2022), Gut, 71, 1919 - 1922

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization.

Harvala H. et al, (2022), Transfusion, 62, 1347 - 1354

Comparison of CpG- and UpA-mediated restriction of RNA virus replication in mammalian and avian cells and investigation of potential ZAP-mediated shaping of host transcriptome compositions.

Odon V. et al, (2022), RNA

SARS-CoV-2 within-host diversity and transmission

Lythgoe KA. et al, (2021), Science (New York, N.Y.), 372

Recommendations for the introduction of metagenomic next-generation sequencing in clinical virology, part II: bioinformatic analysis and reporting.

de Vries JJC. et al, (2021), J Clin Virol, 138

Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.

Ratcliff J. and Simmonds P., (2021), Virology, 556, 62 - 72

Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure.

López-Labrador FX. et al, (2020), J Clin Virol, 134

Impact of virus subtype and host IFNL4 genotype on large-scale RNA structure formation in the genome of hepatitis C virus.

Simmonds P. et al, (2020), RNA, 26, 1541 - 1556

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.

Thompson CP. et al, (2020), Euro Surveill, 25

Binomial nomenclature for virus species: a consultation.

Siddell SG. et al, (2020), Arch Virol, 165, 519 - 525

Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus.

Fawsitt CG. et al, (2020), Value Health, 23, 180 - 190

Analysis of Spounaviruses as a Case Study for the Overdue Reclassification of Tailed Phages.

Barylski J. et al, (2020), Syst Biol, 69, 110 - 123

A functional investigation of the suppression of CpG and UpA dinucleotide frequencies in plant RNA virus genomes.

Ibrahim A. et al, (2019), Sci Rep, 9

Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C.

Childs K. et al, (2019), J Hepatol, 71, 1099 - 1105

The role of ZAP and OAS3/RNAseL pathways in the attenuation of an RNA virus with elevated frequencies of CpG and UpA dinucleotides.

Odon V. et al, (2019), Nucleic Acids Res, 47, 8061 - 8083

Interferon lambda 4 impacts the genetic diversity of hepatitis C virus.

Ansari MA. et al, (2019), Elife, 8

Changes to virus taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2019).

Walker PJ. et al, (2019), Arch Virol, 164, 2417 - 2429

Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.

Atcheson E. et al, (2019), Hepatology

Load More

1
2
3
4
5
6
7
...
»